News

Tempest Therapeutics Announces Stock Options Inducement Grant

Tempest Therapeutics Announces Stock Options Inducement Grant

Tempest Announces Inducement Grant Under Nasdaq Listing Rule

Tempest Therapeutics, Inc. (Nasdaq: TPST), a biotechnology company in the clinical stage that is focused on developing innovative targeted and immune-mediated therapies for cancer, has revealed that the Compensation Committee of its Board of Directors has granted an employee nonqualified stock options, allowing the purchase of a total of 60,000 shares of its common stock under the Company’s 2023 Inducement Plan.

Details of the Stock Option Grant

The stock options will vest over a four-year timeframe. Specifically, 25% of these options will become available on the first anniversary of the employee’s start date, while the remaining shares will vest at a rate of 1/48th each month thereafter, provided the employee remains with the company at each vesting date. This structured vesting approach not only motivates the employee but also aligns their interests with the company's long-term objectives.

About Tempest Therapeutics

Tempest Therapeutics is dedicated to advancing a diverse range of small molecule product candidates that utilize tumor-targeted and/or immune-mediated mechanisms to potentially treat various tumors. The company’s innovative research spans from early-stage investigations to more advanced clinical trials, including a randomized global study aimed at first-line cancer patients. This reflects Tempest's commitment to redefining cancer treatment through carefully developed therapies.

Company’s Vision and Goals

At the core of Tempest Therapeutics is a visionary approach to oncology that merges cutting-edge research with practical application. The company is committed to developing transformative therapies that can significantly enhance patient outcomes and prolong survival in difficult cancer cases. By concentrating on both the breadth of development and the depth of therapeutic options, Tempest is uniquely equipped to tackle a wide range of oncological challenges.

Strategic Partnerships and Collaborations

Tempest Therapeutics understands the critical role of collaboration and strategic partnerships in bolstering its research and development initiatives. By partnering with leading research institutions and other biopharmaceutical companies, they enhance their capacity for innovation and expedite the progress of their therapeutic candidates.

Future Prospects

As Tempest looks to the future, it is well-positioned for growth. With ongoing clinical trials and the accumulation of additional data, the company remains committed to advancing its pipeline. The strategic choices made today, supported by skilled leadership and scientific expertise, are laying the foundation for significant advancements in cancer treatment.

Investor & Media Contacts

For any inquiries or further information, please reach out to:

Sylvia Wheeler
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

Frequently Asked Questions

What is the purpose of the stock option grant?

The stock option grant is designed to motivate employees by aligning their interests with the long-term goals of the company.

How many shares were included in the stock options grant?

The stock options granted included a total of 60,000 shares of common stock.

What does Tempest Therapeutics focus on?

Tempest Therapeutics specializes in developing targeted and immune-mediated therapies for cancer treatment.

How is the vesting schedule structured for stock options?

The vesting schedule is structured so that 25% of the options vest on the first anniversary of the employee's start date, with the remaining shares vesting monthly thereafter.

Who can be contacted for more information about Tempest Therapeutics?

For investor and media inquiries, you can contact Sylvia Wheeler or Aljanae Reynolds at Wheelhouse Life Science Advisors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Laboratory Filtration Market Expands to $6.55B by 2031

Updated Category News Views 120

A Niche Ready to Explode The laboratory filtration market isn't exactly the sort of thing that grabs headlines in the business section, but its growth is worth giving a second look. By 2031, this market's expected to hit $6.55 billion—up from $4.49 billion in 2026. If you think that's not impressive, chew on a 7.9% CAGR for the next few years. That's like watching your...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 113

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 77

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 147

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 121

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 83

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 126

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 92

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 219

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading

Top 5 Most Recently Viewed Articles

New Research Grants Support Diet Impact on Health Outcomes

Updated Category News Views 85

New Research Grants Empower Understanding of Diet and Health Healthcare technology company Komodo Health has recently announced the recipients of its 2024 Diet-Related Health (DRH) grants. These grants are aimed at advancing research that explores the pivotal influence of diet on various health outcomes. Funded by the Robert Wood Johnson Foundation (RWJF), the DRH program...

Continue Reading
Innovative Cardiology Care with Dr. Butkevich's Hybrid Choice™

Updated Category News Views 118

Dr. Alexander Butkevich Introduces Hybrid Choice™ Concierge Program Patients in the Houston area can now access a unique cardiology service from Dr. Alexander Butkevich, MD, thanks to Concierge Choice Physicians. This innovative program provides enhanced connectivity and personalized care adjustments, catering to the evolving needs of patients. The Unique Benefits of...

Continue Reading
Revolutionizing Cryptocurrency with ALR MINER's AI Cloud Service

Updated Category News Views 274

Revolutionizing Cryptocurrency Mining ALR MINER has emerged as a pioneering force in the cryptocurrency world by launching a groundbreaking zero-cost AI cloud mining platform. This innovative approach gives users the opportunity to earn cryptocurrencies like Bitcoin, Ethereum, Dogecoin, and Ripple without any upfront costs, reshaping the way mining is perceived and...

Continue Reading
Instacart Positioned Well Amid Competition with Major Rivals

Updated Category News Views 279

Instacart's Competitive Landscape Instacart (NASDAQ:CART) has made a notable mark in the online grocery delivery sector, and analysts from Goldman Sachs believe its stock is already reflecting the ongoing competition. Despite challenges from giants like Amazon, Uber, and DoorDash, there are reasons to maintain a bullish outlook on Instacart. Supporting Recommendation from...

Continue Reading
Daily Mango Benefits: Heart Health Insights for Women

Updated Category News Views 238

Exploring Mango's Heart Health Benefits Mangos have long been celebrated for their vibrant flavor and nutritional perks. Recent studies now emerge, shedding light on the potential heart and metabolic health benefits of daily mango consumption, particularly for postmenopausal women. This demographic faces unique challenges as they navigate changes in their bodies and...

Continue Reading